Virotherapy - Cancer targeted pharmacology
Building on their success in vaccination, many groups are now exploring the use of viruses as anticancer agents. In general, viral therapeutics provide the possibility to express anticancer proteins directly at the tumour site, decreasing exposure to normal tissue during delivery and maximising ther...
Auteurs principaux: | Tedcastle, A, Cawood, R, Di, Y, Fisher, K, Seymour, L |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
2012
|
Documents similaires
-
Virotherapy--cancer targeted pharmacology.
par: Tedcastle, A, et autres
Publié: (2012) -
Tropism ablation and stealthing of oncolytic adenovirus enhances systemic delivery to tumors and improves virotherapy of cancer.
par: Green, N, et autres
Publié: (2012) -
Comparison of molecular strategies for breast cancer virotherapy using oncolytic adenovirus.
par: Bazan-Peregrino, M, et autres
Publié: (2008) -
Effects of Producer Cell Type on the Properties of Oncolytic Sindbis Virus
par: Kueberuwa, G, et autres
Publié: (2011) -
Combining virotherapy and angiotherapy for the treatment of breast cancer.
par: Bazan-Peregrino, M, et autres
Publié: (2013)